Dose-response modeling of early molecular and cellular key events in the CAR-mediated hepatocarcinogenesis pathway.
about
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge aheadChemical and Hormonal Effects on STAT5b-Dependent Sexual Dimorphism of the Liver TranscriptomeIdentification of chemical modulators of the constitutive activated receptor (CAR) in a gene expression compendiumDisruption of STAT5b-Regulated Sexual Dimorphism of the Liver Transcriptome by Diverse Factors Is a Common EventMode of action analysis for pesticide-induced rodent liver tumours involving activation of the constitutive androstane receptor: relevance to human cancer risk.Editor's Highlight: Dose-Response Analysis of RNA-Seq Profiles in Archival Formalin-Fixed Paraffin-Embedded Samples.Sodium bisulfite pyrosequencing revealed that developmental exposure to environmental contaminant mixtures does not affect DNA methylation of DNA repeats in Sprague-Dawley rats.Risk assessments for chronic exposure of children and prospective parents to ethylbenzene (CAS No. 100-41-4).Dose-response analysis of epigenetic, metabolic, and apical endpoints after short-term exposure to experimental hepatotoxicants.Dose and Effect Thresholds for Early Key Events in a PPARα-Mediated Mode of Action.Mechanistic Investigation of Toxaphene Induced Mouse Liver Tumors.Sex-Differential Responses of Tumor Promotion-Associated Genes and Dysregulation of Novel Long Noncoding RNAs in Constitutive Androstane Receptor-Activated Mouse Liver.Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXR.Toxaphene-induced mouse liver tumorigenesis is mediated by the constitutive androstane receptor.Demodifying RNA for Transcriptomic Analyses of Archival Formalin-Fixed Paraffin-Embedded Samples.Latent carcinogenicity of early-life exposure to dichloroacetic acid in mice.Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators
P2860
Q28397132-CD8BD525-2EC7-430B-AAEA-643E5507EE43Q28550623-909B9C0A-5B94-4BAE-9703-F038F7B0B150Q35575682-A16A3FC9-3729-4DB8-BD49-30D40F4C1407Q35951283-3C2AD788-4042-4EB3-98C1-1FB3E8F19A72Q38232042-F8D7315D-FF79-4F08-B4B8-84E78E5BF5B6Q38378627-9461F1BE-08FA-43E7-B825-CC1C9FCE9F5FQ38383972-7AAD9C8B-1231-4A2F-A49E-55415614DB9FQ38495604-0B340F6C-2A0D-42BD-BF68-E7E789B70DB3Q38791097-339FC255-F102-4C52-97A1-36CF791FE944Q42700243-F078808A-44A1-4CBC-814B-AC534EEBB6D5Q42701176-3C004CA9-E495-4DBB-9831-73723E013C3DQ42777681-CAB3644D-60C1-4F78-9613-8291E912FCE8Q46889611-4342F529-C506-4AF5-A612-796A3536B333Q48218649-58E975CA-8B9A-4FCC-9741-084638B2264EQ49935300-EA5FFB41-3FF0-4E82-98A7-313560615D1EQ51030086-841B82CE-4346-4EC3-BFC4-4192A0048945Q57096055-16720052-13A9-47A1-96CD-35BA6FCFEAB0
P2860
Dose-response modeling of early molecular and cellular key events in the CAR-mediated hepatocarcinogenesis pathway.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Dose-response modeling of earl ...... hepatocarcinogenesis pathway.
@en
Dose-response modeling of earl ...... hepatocarcinogenesis pathway.
@nl
type
label
Dose-response modeling of earl ...... hepatocarcinogenesis pathway.
@en
Dose-response modeling of earl ...... hepatocarcinogenesis pathway.
@nl
prefLabel
Dose-response modeling of earl ...... hepatocarcinogenesis pathway.
@en
Dose-response modeling of earl ...... hepatocarcinogenesis pathway.
@nl
P2093
P2860
P356
P1476
Dose-response modeling of earl ...... hepatocarcinogenesis pathway.
@en
P2093
B Bhaskar Gollapudi
David R Geter
Radhakrishna Sura
Susan D Hester
Virunya S Bhat
P2860
P304
P356
10.1093/TOXSCI/KFU014
P577
2014-01-21T00:00:00Z